IHS Chemical Week

Regions :: North America :: U.S.

BASF and Bend Research collaborate to improve solubility and bioavailability of drugs

11:12 AM MST | February 21, 2013 | Deepti Ramesh

BASF says that it has signed an agreement with Bend Research (Bend, OR) to jointly evaluate and develop novel excipients to enhance the solubility and bioavailability of poorly soluble drugs. Bioavailability is the measure of the amount of drug that is actually absorbed from a given dose.  Bend Research is a company that provides formulation and dosage-form support, assists in process development and optimization, manufactures clinical trial quantities of drug candidates in its facilities, and advances promising drug candidates from conception through...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa